H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.1% of adults in Provo have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Census population 115,162. Utah Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Provo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Provo storefront.
Biologic Therapy for Osteoarthritis in Provo, UT for clinics & physicians. Biologic therapy options for os… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 14.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 6.1% of adults in Provo have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Together those PLACES numbers are why a city under 250k still needs separate PRP and CTP protocols. osteoarthritis biologic therapy inventory is national; utilization is JF-local.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)CDC PLACES (2023, crude) estimates 6.1% of adults in Provo have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Adult obesity in Provo is 30.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 14.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, ND, OR, SD, WA, WY. Utah Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JF articles mapped. 12.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 6.1% of adults — 5.9 points below the U.S. 12% figure. Obesity is 30.7%; arthritis is 14.1%. That is place-level BRFSS modeling, not a clinic census and not a Provo trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Noridian Healthcare Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers biologic therapy for osteoarthritis and which products they use.
Ask for the IFU, the lot-traceability packet, and the Noridian Healthcare Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Provo fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Provo, UT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Provo is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Provo — 5.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Utah Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Provo. Useful for joint-program math; still needs a diagnosis and privileging.
No Provo storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.